A successful pregnancy in a patient with Takayasu's arteritis

Bernhard Kraemer1, Harald Abele, Markus Hahn

  • 1University Hospital for Women, Tuebingen, Germany. bernhard.kraemer@med.uni-tuebingen.de

Insights

Takayasu

Area of Science:

  • Cardiology
  • Rheumatology
  • Obstetrics

Background:

  • Takayasu's arteritis is a rare, chronic inflammatory condition affecting large arteries like the aorta.
  • Pregnancy in women with Takayasu's arteritis requires careful management due to potential cardiovascular complications.

Observation:

  • A patient with a 7-year history of Takayasu's arteritis conceived and continued treatment with adalimumab, leflunomide, and prednisolone.
  • The pregnancy proceeded with ongoing medical management, including medication adjustments.

Findings:

  • The patient successfully carried the pregnancy to term, delivering a healthy infant via cesarean section at 37 weeks.
  • No significant maternal or fetal complications were noted during pregnancy or postpartum.

Implications:

  • This case suggests that pregnancy may be achievable in selected Takayasu's arteritis patients with appropriate medical supervision and treatment.
  • Continued medication, including biologics like adalimumab, may be safe and effective during pregnancy for managing Takayasu's arteritis.